Brainsway Ltd. (BWAY): Price and Financial Metrics
BWAY Price/Volume Stats
| Current price | $9.24 | 52-week high | $10.98 |
| Prev. close | $8.96 | 52-week low | $4.61 |
| Day low | $8.82 | Volume | 56,200 |
| Day high | $9.35 | Avg. volume | 92,969 |
| 50-day MA | $9.84 | Dividend yield | N/A |
| 200-day MA | $7.41 | Market Cap | 173.83M |
BWAY Stock Price Chart Interactive Chart >
Brainsway Ltd. (BWAY) Company Bio
Brainsway Ltd. engages in the research, development and marketing of medical device for non-invasive treatment of the brain disorders. Its technology enables handling of a wide range of indications through the TMS Deep system developed by the company. Brainsway operates through the following segments: Major depression and Obsessive Compulsive Disorder (OCD). The company was founded by Avner Hagai, Yiftach Roth, Abraham Zangen, and David Zacut on November 7, 2006 and is headquartered in Jerusalem, Israel.
BWAY Price Returns
| 1-mo | -7.60% |
| 3-mo | 12.82% |
| 6-mo | 47.84% |
| 1-year | 30.69% |
| 3-year | 23.04% |
| 5-year | N/A |
| YTD | 42.59% |
| 2023 | 162.35% |
| 2022 | -67.92% |
| 2021 | 2.12% |
| 2020 | -22.67% |
| 2019 | N/A |
Loading social stream, please wait...